Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Hongzhou Lu and Xianmin Meng.
Hongzhou Lu
Connection Strength
1.869
Xianmin Meng
  1. Safety, tolerability, pharmacokinetic characteristics, and immunogenicity of MW33: a Phase 1 clinical study of the SARS-CoV-2 RBD-targeting monoclonal antibody. Emerg Microbes Infect. 2021 Dec; 10(1):1638-1648.
    View in: PubMed
    Score: 0.982
  2. Potential for jaktinib hydrochloride to treat cytokine storms in patients with COVID-19. Biosci Trends. 2020 Jul 17; 14(3):161-167.
    View in: PubMed
    Score: 0.887
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.